Recombinant multi-species 5 Lipoxygenase/ALOX5/5-LOX protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine 5 Lipoxygenase/ALOX5/5-LOX protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the lipoxygenase gene family and plays a dual role in the synthesis of leukotrienes from arachidonic acid. The encoded protein, which is expressed specifically in bone marrow-derived cells, catalyzes the conversion of arachidonic acid to 5(S)-hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid, and further to the allylic epoxide 5(S)-trans-7,9-trans-11,14-cis-eicosatetrenoic acid (leukotriene A4). Leukotrienes are important mediators of a number of inflammatory and allergic conditions. Mutations in the promoter region of this gene lead to a diminished response to antileukotriene drugs used in the treatment of asthma and may also be associated with atherosclerosis and several cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
The Alternative Names of target: 5 Lipoxygenase,5-LO,5-LOX,5-lipoxygenase),5LO,5LPG,5LX,ALOX5,Alox5,Arachidonate 5-lipoxygenase (5-LO,F730011J02,LOG5,LOX5A,Polyunsaturated fatty acid 5-lipoxygenase
Go
to 5 Lipoxygenase/ALOX5/5-LOX products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T00140-Ag-1/ GM-Tg-hg-T00140-Ag-2 | Human 5 Lipoxygenase/ALOX5/5-LOX protein | Human |
| GM-Tg-rg-T00140-Ag-1/ GM-Tg-rg-T00140-Ag-2 | Rat 5 Lipoxygenase/ALOX5/5-LOX protein | Rat |
| GM-Tg-mg-T00140-Ag-1/ GM-Tg-mg-T00140-Ag-2 | Mouse 5 Lipoxygenase/ALOX5/5-LOX protein | Mouse |
| GM-Tg-cynog-T00140-Ag-1/ GM-Tg-cynog-T00140-Ag-2 | Cynomolgus/Rhesus macaque 5 Lipoxygenase/ALOX5/5-LOX protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T00140-Ag-1/ GM-Tg-felg-T00140-Ag-2 | Feline 5 Lipoxygenase/ALOX5/5-LOX protein | Feline |
| GM-Tg-cang-T00140-Ag-1/ GM-Tg-cang-T00140-Ag-2 | Canine 5 Lipoxygenase/ALOX5/5-LOX protein | Canine |
| GM-Tg-bovg-T00140-Ag-1/ GM-Tg-bovg-T00140-Ag-2 | Bovine 5 Lipoxygenase/ALOX5/5-LOX protein | Bovine |
| GM-Tg-equg-T00140-Ag-1/ GM-Tg-equg-T00140-Ag-2 | Equine 5 Lipoxygenase/ALOX5/5-LOX protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T00140-Ag-1/ GM-Tg-hg-T00140-Ag-2;
GM-Tg-rg-T00140-Ag-1/ GM-Tg-rg-T00140-Ag-2;
GM-Tg-mg-T00140-Ag-1/ GM-Tg-mg-T00140-Ag-2; GM-Tg-cynog-T00140-Ag-1/ GM-Tg-cynog-T00140-Ag-2; GM-Tg-felg-T00140-Ag-1/ GM-Tg-felg-T00140-Ag-2; GM-Tg-cang-T00140-Ag-1/ GM-Tg-cang-T00140-Ag-2; GM-Tg-bovg-T00140-Ag-1/ GM-Tg-bovg-T00140-Ag-2; GM-Tg-equg-T00140-Ag-1/ GM-Tg-equg-T00140-Ag-2 |
| Products Name | 5 Lipoxygenase/ALOX5/5-LOX protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | 5 Lipoxygenase/ALOX5/5-LOX |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine 5 Lipoxygenase/ALOX5/5-LOX protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.